Manulife (Manufacturers Life Insurance)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,466
Closed -$12.5M 3031
2022
Q3
$12.5M Sell
50,466
-173
-0.3% -$46.7K 0.01% 723
2022
Q2
$12.7M Sell
50,639
-450
-0.9% -$121K 0.01% 742
2022
Q1
$16.9M Buy
51,089
+16,731
+49% +$5.15M 0.01% 709
2021
Q4
$12.3K Sell
34,358
-8,079
-19% -$2.73M 0.01% 851
2021
Q3
$13.8M Sell
42,437
-1,657
-4% -$561K 0.01% 791
2021
Q2
$13.8M Sell
44,094
-608
-1% -$187K 0.01% 822
2021
Q1
$14.2M Sell
44,702
-19
-0% -$6.08K 0.01% 801
2020
Q4
$14.5M Sell
44,721
-2,836
-6% -$784K 0.01% 737
2020
Q3
$13.2M Sell
47,557
-531
-1% -$153K 0.01% 682
2020
Q2
$11.6M Sell
48,088
-956
-2% -$192K 0.01% 722
2020
Q1
$7.12M Buy
49,044
+6,642
+16% +$1.1M 0.01% 863
2019
Q4
$7.23M Sell
42,402
-2,510
-6% -$465K 0.01% 1023
2019
Q3
$7.9M Buy
44,912
+3,031
+7% +$655K 0.01% 953
2019
Q2
$10.9M Sell
41,881
-2,618
-6% -$695K 0.01% 788
2019
Q1
$12.7M Sell
44,499
-189
-0.4% -$62.8K 0.01% 739
2018
Q4
$14.5M Buy
44,688
+12,627
+39% +$4.39M 0.02% 610
2018
Q3
$14.4M Sell
32,061
-16,661
-34% -$6.57M 0.02% 707
2018
Q2
$19.9M Sell
48,722
-18,513
-28% -$6.71M 0.02% 590
2018
Q1
$19.6M Sell
67,235
-2,287
-3% -$580K 0.02% 589
2017
Q4
$13M Buy
69,522
+8,059
+13% +$1.5M 0.01% 739
2017
Q3
$10.4M Buy
61,463
+1,565
+3% +$237K 0.01% 795
2017
Q2
$8.58M Buy
59,898
+1,375
+2% +$185K 0.01% 906
2017
Q1
$7.33M Buy
58,523
+3,501
+6% +$406K 0.01% 972
2016
Q4
$6.2M Buy
55,022
+122
+0.2% +$14.1K 0.01% 982
2016
Q3
$7.06M Buy
54,900
+1,688
+3% +$202K 0.01% 870
2016
Q2
$5.82M Sell
53,212
-24,414
-31% -$2.43M 0.01% 944
2016
Q1
$7.22M Buy
77,626
+50,360
+185% +$4.25M 0.01% 846
2015
Q4
$2.46K Buy
27,266
+264
+1% +$22.4K ﹤0.01% 1349
2015
Q3
$2.5K Buy
27,002
+661
+3% +$58.2K ﹤0.01% 1315
2015
Q2
$1.73K Buy
26,341
+45
+0.2% +$2.99K ﹤0.01% 1453
2015
Q1
$1.88K Buy
26,296
+856
+3% +$46.5K ﹤0.01% 1412
2014
Q4
$968 Sell
25,440
-643
-2% -$20.3K ﹤0.01% 1596
2014
Q3
$647 Buy
26,083
+789
+3% +$20K ﹤0.01% 1825
2014
Q2
$636K Sell
25,294
-3,966
-14% -$92.3K ﹤0.01% 1879
2014
Q1
$762 Sell
29,260
-237
-0.8% -$6.56K ﹤0.01% 1816
2013
Q4
$789 Sell
29,497
-815
-3% -$20.1K ﹤0.01% 1759
2013
Q3
$578 Sell
30,312
-925
-3% -$21.1K ﹤0.01% 1907
2013
Q2
$673K Buy
+31,237
New +$628K ﹤0.01% 1697

Other funds holding ABMD

Manulife (Manufacturers Life Insurance)'s ABMD Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 50,466 shares — an estimated $12.5M sold.

Manulife (Manufacturers Life Insurance) first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $19.9M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 50,466 Abiomed Inc shares in Q4 2022, an estimated $12.5M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
  • Manulife (Manufacturers Life Insurance)'s Abiomed Inc position peaked at $19.9M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.